Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 5:51 pm Sale | 2025-08-22 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 7,008,590 3.000% | -1,085,922 (-13.42%) | Filing History |
| 2024-12-12 4:39 pm Sale | 2024-12-10 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 8,094,512 6.800% | -437,188 (-5.12%) | Filing History |
| 2023-02-07 5:05 pm Unchanged | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V, L.P. | 28,475 4.500% | 0 (Unchanged) | Filing History |
| 2022-06-24 4:47 pm Unchanged | 2022-06-22 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 8,531,700 7.800% | 0 (Unchanged) | Filing History |
| 2022-04-25 9:41 pm Unchanged | 2022-04-25 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 8,531,700 7.800% | 0 (Unchanged) | Filing History |
| 2022-03-30 07:37 am Unchanged | 2022-03-28 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 8,531,700 7.700% | 0 (Unchanged) | Filing History |
| 2021-08-20 4:21 pm Purchase | 2021-08-10 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V, L.P. | 8,531,700 7.700% | 8,531,700 (New Position) | Filing History |
| 2021-02-12 5:15 pm Unchanged | 2020-12-31 | 13G | Phreesia, Inc. PHR | Polaris Venture Partners V, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 5:10 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V, L.P. | 28,475 11.000% | 28,475 (New Position) | Filing History |